Serif Biomedicines, a Cambridge, MA-based biotech developing modified DNA, raised $50 million in an initial commitment financing led by Flagship Pioneering.
More on VC News Daily →
Serif Biomedicines, a Cambridge, MA-based biotech developing modified DNA, raised $50 million in an initial commitment financing led by Flagship Pioneering.
More on VC News Daily →
PlaqueTec, a Cambridge, England-based cardiovascular disease data...
Patronus, a Berlin-based digital safety for seniors, raised €11 million...
BioOrbit, a London-based in-space drug manufacturing company, raised £9.8...
Coral, a New York-based healthcare admin automation platform, raised $12.5...
Betterness, Inc., a Miami-based AI wellness and coaching platform, raised...
Nervonik, a Los Angeles-based peripheral nerve stimulation therapy...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.